Nicole Negar Davarpanah - May 1, 2025 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role: Chief Medical Officer
Signature: /s/ Shane Ward, Attorney-in-Fact
Stock symbol: CDTX
Transactions as of: May 1, 2025
Transactions value $: $0
Form type: 4
Date filed: 5/12/2025, 08:40 PM
Next filing: Sep 15, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Davarpanah Nicole Negar	Chief Medical Officer	6310 NANCY RIDGE DRIVE, SUITE 101, SAN DIEGO	/s/ Shane Ward, Attorney-in-Fact	2025-05-12	0002067554

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CDTX	Common Stock	Award	$0	+10K	+46.1%	$0.00	31.7K	May 1, 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CDTX	Employee Stock Option (right to buy)	Award	$0	+20K		$0.00	20K	May 1, 2025	Common Stock	20K	$21.75	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents time-based Restricted Stock Units (RSUs) granted on May 1, 2025. All RSUs vest in three equal annual installments, with 1/3 vesting on each of June 10, 2026, 2027, and 2028, subject to continuous service through each such Vesting Date.
F2	The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of May 1, 2025, subject to continuous service through each such Vesting Date.